After Hours
$
103.91
Change
+0.01 +0.0096%
Volume
Volume 68,420
Oct 28, 2016, 7:57 p.m.
Quotes are delayed by 20 min
Previous close
$ 104.72
$ 103.90
Change
-0.82 -0.78%
Day low
Day high
$102.61
$105.19
52 week low
52 week high
$93.05
$127.97
Market cap
$80.53B
Average volume
3.88M
P/E ratio
39.36
Rev. per Employee
$1.53M
EPS
2.64
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on CELG
-
11 improving health-care companies whose stocks are loved by analysts
- Philip van Doorn
-
Stock market ends lower on mixed earnings, defensive sector weakness
- Wallace Witkowski
-
Celgene tops estimates and raises outlook
- MarketWatch.com
-
Buy these few standout stocks that are escaping the ‘earnings reaper’
- Victor Reklaitis
-
Biotech stocks have plenty of catalysts around the corner
- Michael Brush
-
Growth stocks could replace dividend stocks as star performers
- Philip van Doorn
-
7 cheap growth stocks for double-digit profit gains in 2017
- Philip van Doorn
-
Franklin fund manager loads up on banks as profits rise
- Philip van Doorn
-
Pfizer's Medivation deal isn't new for drug maker
- MarketWatch.com
-
Dow industrials tag record highs, breakout attempt underway
- Michael Ashbaugh
-
Celgene raises outlook as Revlimid sales rise
- MarketWatch.com
-
Jounce Therapeutics and Celgene to collaborate on cancer treatments
- Emma Court
-
Four high-quality biotech companies trading like risky startups
- Michael Brush
-
Sanofi, Pfizer, Celgene may each pursue Medivation takeover
- Noemie Bisserbe
-
Three ways to profit as investors panic about Brexit
- Michael Brush
-
Brexit means little for biotech stocks, analyst says
- Emma R. Court
-
Health-care stocks rally as Medicare cost-cutting not triggered
- Wallace Witkowski
- Loading more headlines...
Where does this data come from?
Analyst Estimates »
A data point based on hundreds of brokers buy, sell and hold rating.
Sentiment on CELG
Analyst Ratings
Other News on CELG
-
5 Things Amgen Inc.'s Management Wants You to Know
- Motley Fool
-
Celgene Corporation Is Firing on All Cylinders
- Motley Fool
-
Biogen Reported a Positive Financial Performance in 3Q16
- MarketRealist.com
-
- Seeking Alpha
-
2 Reasons Celgene Corporation's Future Just Got Brighter
- Motley Fool
-
Week In Review: Apple, Amazon, Alphabet Are A-Listers On Crowded Earnings Stage
- Investors Business Daily
-
Stock Market News for October 28, 2016
- Zacks.com
-
Wall Street Breakfast: Traders Look To GDP Report
- Seeking Alpha
-
Biogen Flat For 3 Years While EPS Rise 150%; Is It A Buy Yet?
- Seeking Alpha
-
Biggest Movers in Manufacturing Stocks Now – ONCS CALA IPGP CFX
- InvestorPlace.com
-
- Edgar Online - (EDG = 10Q, 10K)
-
Celgene (CELG) Q3 2016 Results - Earnings Call Transcript
- Seeking Alpha
-
Celgene Delivers a Blockbuster Quarter
- Motley Fool
-
Celgene Corporation 2016 Q3 - Results - Earnings Call Slides
- Seeking Alpha
- Loading more headlines...
Earnings Announcement
-
Celgene (CELG) Q3 2016 Results - Earnings Call Transcript
- Seeking Alpha
Press Releases on CELG
-
Celgene Corporation to Webcast at Upcoming Investor Conferences in November
- BusinessWire - BZX
-
Blog Coverage Celgene and Agios Team up with Abbott
- ACCESSWIRE
-
Celgene to Present New Data on Investigational Compounds at UEGW and ACG Congresses
- BusinessWire - BZX
-
Celgene Corporation to Announce Third Quarter 2016 Results on October 27, 2016
- BusinessWire - BZX
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com
| Avg. APR | Last Week | 6 Months | |
|---|---|---|---|
| Low Interest | 12.00% | 12.00% | 11.96% |
| Business | 13.12% | 13.12% | 13.12% |
| Student | 13.42% | 13.42% | 13.42% |
| Balance Transfer | 14.41% | 14.41% | 14.39% |
| Airline | 15.13% | 15.13% | 15.17% |
| Reward | 15.24% | 15.24% | 15.30% |
| Cash Back | 15.33% | 15.33% | 15.30% |
| Instant Approval | 17.86% | 17.86% | 18.04% |
| Bad Credit | 22.86% | 22.86% | 22.56% |




